Evaluation of the effects of erythropoietin and interleukin-6 in rats submitted to acute spinal cord injury
Carregando...
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
HOSPITAL CLINICAS, UNIV SAO PAULO
Autores
Citação
CLINICS, v.74, article ID e674, 8p, 2019
Resumo
OBJECTIVE: To evaluate the effects of interleukin-6 (IL-6) and erythropoietin (EPO) in experimental acute spinal cord injury (SCI) in rats. METHODS: Using standardized equipment, namely, a New York University (NYU) Impactor, a SCI was produced in 50 Wistar rats using a 10-g weight drop from a 12.5-mm height. The rats were divided into the following 5 groups of 10 animals each: ""Group EPO"", treated with erythropoietin only; ""Group EPO + IL-6"", treated with both substances; ""Group IL-6"", receiving IL-6 administration only; ""Group Placebo"", receiving a placebo solution; and ""Group Sham"", submitted to an incomplete procedure (only laminectomy, without SCI). All drugs and the placebo solution were administered intraperitoneally for three weeks. The animals were followed up for 42 days. Functional motor recovery was monitored by the Basso, Beattie, and Bresnahan (BBB) scale on days 2, 7, 14, 21, 28, 35 and 42. Motor-evoked potential tests were performed on the 42nd day. Histological analysis was performed after euthanasia. RESULTS: The group receiving EPO exhibited superior functional motor results on the BBB scale. IL-6 administration alone was not superior to the placebo treatment, and the IL-6 combination with EPO yielded worse results than did EPO alone. CONCLUSIONS: Using EPO after acute SCI in rats yielded benefits in functional recovery. The combination of EPO and IL-6 showed benefits, but with inferior results compared to those of isolated EPO; moreover, isolated use of IL-6 resulted in no benefit.
Palavras-chave
Interleukin-6, Erythropoietin, Spinal Cord Injuries, Central Nervous System/Injuries, Rats
Referências
- Arishima Y, 2006, SPINE, V31, P2432, DOI 10.1097/01.brs.0000239124.41410.7a
- Atkins S, 2007, J PERIPHER NERV SYST, V12, P269, DOI 10.1111/j.1529-8027.2007.00148.x
- Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284
- Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098
- Bethea JR, 2000, PROG BRAIN RES, V128, P33
- Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021
- Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714
- Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597
- Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687
- Burnett Mark G, 2004, Neurosurg Focus, V16, pE1, DOI 10.3171/foc.2004.16.5.2
- Cayli SR, 2004, EUR SPINE J, V13, P724, DOI 10.1007/s00586-003-0550-y
- Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799
- Cristante AF, 2013, SPINAL CORD, V51, P501, DOI 10.1038/sc.2013.18
- Cristante AF, 2012, SPINAL CORD, V50, P502, DOI 10.1038/sc.2012.16
- Cristante AF, 2009, SPINAL CORD, V47, P733, DOI 10.1038/sc.2009.24
- Cristante AF, 2009, SPINAL CORD, V47, P458, DOI 10.1038/sc.2008.155
- Cristante AF, 2012, CLINICS, V67, P1219, DOI 10.6061/clinics/2012(10)16
- Coutinho PRD, 2016, SPINAL CORD, V54, P439, DOI 10.1038/sc.2015.172
- dos Santos GB, 2011, ACTA ORTOP BRAS, V19, P87, DOI 10.1590/S1413-78522011000200005
- Ferreira Ricardo, 2005, Acta ortop. bras., V13, P112, DOI 10.1590/S1413-78522005000300002
- Fu ES, 2005, CURR OPIN ANESTHESIO, V18, P181, DOI 10.1097/01.aco.0000162838.56344.88
- Glick T., 2000, J SPINAL CORD MED S, V23, P61
- Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899
- Grasso G, 2005, NEUROSURGERY, V56, P821, DOI 10.1227/01.NEU.0000156493.00904.7E
- Grothe C, 2000, BRAIN RES, V885, P172, DOI 10.1016/S0006-8993(00)02911-5
- Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184
- Hurlbert RJ, 2000, J NEUROSURG, V93, P1, DOI 10.3171/spi.2000.93.1.0001
- Inserra MM, 2000, ARCH OTOLARYNGOL, V126, P1112, DOI 10.1001/archotol.126.9.1112
- Iyer S, 2010, J NEUROSCI METH, V193, P210, DOI 10.1016/j.jneumeth.2010.08.017
- Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y
- Klusman I, 1997, BRAIN RES, V762, P173, DOI 10.1016/S0006-8993(97)00381-8
- Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9
- Lee HK, 2009, J NEUROCHEM, V108, P776, DOI 10.1111/j.1471-4159.2008.05826.x
- Letaif OB, 2015, CLINICS, V70, P700, DOI 10.6061/clinics/2015(10)08
- Mann C, 2008, EXP NEUROL, V211, P34, DOI 10.1016/j.expneurol.2007.12.013
- Marcon RM, 2010, SPINAL CORD, V48, P808, DOI 10.1038/sc.2010.37
- Marcon RM, 2016, CLINICS, V71, P351, DOI 10.6061/clinics/2016(06)11
- Marcon RM, 2010, ACTA ORTOP BRAS, V18, P26, DOI 10.1590/S1413-78522010000100005
- Mofidi A, 2011, MINI-REV MED CHEM, V11, P763, DOI 10.2174/138955711796355267
- Qian T, 2005, SPINAL CORD, V43, P199, DOI 10.1038/sj.sc.3101681
- Schroeter M, 2005, NEUROMOL MED, V7, P183, DOI 10.1385/NMM:7:3:183
- Sekiguchi Y, 2003, SPINE, V28, P2577, DOI 10.1097/01.BRS.0000096674.12519.12
- Short D, 2001, CURR OPIN NEUROL, V14, P759, DOI 10.1097/00019052-200112000-00013
- Sipe KJ, 1996, MOL BRAIN RES, V38, P222, DOI 10.1016/0169-328X(95)00310-O
- Squadrito F, 1999, BRIT J PHARMACOL, V127, P482, DOI 10.1038/sj.bjp.0702521
- Tansey MG, 2008, FRONT BIOSCI-LANDMRK, V13, P709, DOI 10.2741/2713
- Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067
- Yang LQ, 2004, SPINE, V29, P966, DOI 10.1097/00007632-200405010-00004
- Zhang Minghuang, 1998, P517